CM, a clinically complex syndrome of coma and potentially reversible encephalopathy, is associated with increased levels of proinflammatory cytokines like tumor necrosis factor (TNF)-α, interferon (IFN)-γ and lymphotoxin [6,7], and increasingly recognized long-term sequelae in survivors [7-15]. This evidence concerns the gene TNF and cutaneous mastocytosis.